Table of Contents
Volume 2 | Issue 3
Publication Date: December 2003- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Meeting Highlights | ||
137-141 |
Highlights from the XII European Cancer Conference; Copenhagen, Denmark Preeta Tyagi, Nancy Price, Kesava Reddy, Jennifer Klem, Vinay K. Jain, Oliver Sartor |
|
Research in Brief | ||
143-145 |
The Anti-HER2 Monoclonal Antibody Pertuzumab May Be Effective in Androgen-Independent Prostate Cancer Heather DeGrendele, Vinay K. Jain |
|
Comprehensive Reviews | ||
147-152 |
Complications of Androgen-Deprivation Therapy for Prostate Cancer Jeffrey M. Holzbeierlein, Erik P. Castle, J. Brantley Thrasher |
|
153-159 |
The Combination of Antiangiogenic and Cytotoxic Agents in the Treatment of Prostate Cancer Avi S. Retter, William D. Figg, William L. Dahut |
|
160-166 |
Clinical Strategies in the Management of Biochemical Recurrence After Radical Prostatectomy Robert A. Zimmerman, Daniel J. Culkin |
|
Original Contributions | ||
167-172 |
Weekly Docetaxel in Elderly Patients with Prostate Cancer: Efficacy and Toxicity in Patients Aged ≥ 70 Years of Age Compared with Patients Aged < 70 Years Tomasz M. Beer, William Berry, Emily M. Wersinger, Lisa B. Bland |
|
173-176 |
Comparison of Total Prostate-Specific Antigen and Derivative Levels in a Screening Population of Black, White, and Korean-American Men Jae Park, Lori J. Sokoll, Debra J. Bruzek, Leslie Mangold, Robin Gurganus, Masood A. Khan, Alan W. Partin, Daniel W. Chan, Robert W. Veltri |
|
177-180 |
Mutations in Ribonuclease–L Gene Do Not Occur at a Greater Frequency in Patients with Familial Prostate Cancer Compared with Patients with Sporadic Prostate Cancer Sean R. Downing, Kristen T. Hennessy, Miyako Abe, Judith Manola, Daniel J. George, Philip W. Kantoff |
|
Translational Medicine | ||
181-187 |
Therapeutic Approaches Targeting Prostate Cancer Progression Using Novel Voltage-Gated Ion Channel Blockers Robert A. Sikes, Alison M. Walls, W. Nathaniel Brennen, James D. Anderson, Indrani Choudhury-Mukherjee, Hilary A. Schenck, Milton L. Brown |
|
Commentary | ||
188-189 |
Ion Channels as Molecular Targets in Prostate Cancer Jane B. Trepel |
|